ACCESSION: MSBNK-SMB_Measured-HSA015P0316002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 27
COMMENT: RAW_SPEC {'EL01_pos_3255': {'bp': 559389.0, 'sum': 1341291.0}, 'EL13_pos_3255': {'bp': 474370.0, 'sum': 1134447.0}, 'EL03_pos_3355': {'bp': 450119.0, 'sum': 1131696.0}, 'EL02_pos_3267': {'bp': 368902.0, 'sum': 892041.0}, 'EL16_pos_3255': {'bp': 309637.0, 'sum': 749399.0}, 'EL11_pos_3257': {'bp': 299303.0, 'sum': 708457.0}, 'EL04_pos_3255': {'bp': 297123.0, 'sum': 778038.0}, 'EL06_pos_3255': {'bp': 286616.0, 'sum': 700023.0}, 'EL18_pos_3262': {'bp': 264700.0, 'sum': 604477.0}, 'EL07_pos_3250': {'bp': 263708.0, 'sum': 635687.0}, 'EL15_pos_3255': {'bp': 262872.0, 'sum': 639742.0}, 'EL17_pos_3249': {'bp': 254035.0, 'sum': 627270.0}, 'EL14_pos_3261': {'bp': 252881.0, 'sum': 632666.0}, 'EL09_pos_3255': {'bp': 249619.0, 'sum': 619081.0}, 'EL21_pos_3261': {'bp': 236860.0, 'sum': 547463.0}, 'EL08_pos_3251': {'bp': 227174.0, 'sum': 543170.0}, 'EL20_pos_3255': {'bp': 222218.0, 'sum': 518838.0}, 'EL10_pos_3255': {'bp': 221976.0, 'sum': 564031.0}, 'EL05_pos_3263': {'bp': 220830.0, 'sum': 559741.0}, 'EL22_pos_3285': {'bp': 218069.0, 'sum': 541908.0}, 'EL19_pos_3275': {'bp': 210889.0, 'sum': 510186.0}, 'EL24_pos_3267': {'bp': 197901.0, 'sum': 517295.0}, 'EL12_pos_3251': {'bp': 191726.0, 'sum': 467038.0}, 'EL23_pos_3267': {'bp': 178368.0, 'sum': 458287.0}, 'Blanc1-pos_3761': {'bp': 136526.0, 'sum': 357146.0}, 'Blanc2-pos_3213': {'bp': 91851.0, 'sum': 242157.0}, 'Blanc3-pos_3219': {'bp': 84424.0, 'sum': 212597.0}}
COMMENT: RETENTION_TIME_STDEV 0.109
COMMENT: PRECURSOR_M/Z_RAW 316.211887
COMMENT: PRECURSOR_M/Z_STDEV 0.000105
COMMENT: PRECURSOR_IN_MS1 mz 316.211881; int 83.801; delta(ppm) 1.308611
COMMENT: PROPOSED_CHARGE_STATE +1; mz 317.215161; int 14.332; cor 0.951
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.153; C17H25N5O; [M+H]+; delta(ppm) -4.152858
COMMENT: PROPOSED_MF SevenGoldenRules 0.089; C16H29NO5; [M+H]+; delta(ppm) 0.088831
COMMENT: PROPOSED_MF SevenGoldenRules 3.369; C10H30N5O4P; [M+H]+; delta(ppm) 3.369240
COMMENT: PROPOSED_MF MS-FINDER 3.339; C16H29NO5; [M+H]+; delta(ppm) 0.087048
COMMENT: PROPOSED_MF MS-FINDER 2.753; C17H25N5O; [M+H]+; delta(ppm) -4.142422
COMMENT: PROPOSED_MF MS-FINDER 2.318; C9H29N7O3S; [M+H]+; delta(ppm) -2.081748
COMMENT: PROPOSED_MF MS-FINDER 2.236; C10H30N5O4P; [M+H]+; delta(ppm) 3.355629
COMMENT: PROPOSED_MF MS-FINDER 2.009; C17H33NS2; [M+H]+; delta(ppm) -2.661158
COMMENT: PROPOSED_MF SIRIUS5_Sirius 33.914; C16H29NO5; [M+H]+; delta(ppm) 0.087048
COMMENT: PROPOSED_MF SIRIUS5_Sirius 28.246; C17H25N5O; [M+H]+; delta(ppm) -4.142422
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.999; C16H29NO5; [M+H]+; delta(ppm) 0.087048
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C17H25N5O; [M+H]+; delta(ppm) -4.142422
COMMENT: PROPOSED_MF SIRIUS6_Sirius 55.871; C16H29NO5; [M+H]+; delta(ppm) 0.087048
COMMENT: PROPOSED_MF SIRIUS6_Sirius 51.463; C17H25N5O; [M+H]+; delta(ppm) -4.142422
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.084; C12H25N7O3; [M+H]+; delta(ppm) 8.579298
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.589; C14H28F3NO3; [M+H]+; delta(ppm) 7.820139
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.008; C19H27N2O2; [M+H]+; delta(ppm) -8.388457
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.660; C15H33NO2Si2; [M+H]+; delta(ppm) -168205.838722
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.884; C16H33NOSSi; [M+H]+; delta(ppm) -168206.338420
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.574; C14H26FN5O2; [M+H]+; delta(ppm) -7.755949
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.412; C19H29NOSi; [M+H]+; delta(ppm) -168198.962230
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.354; C17H30FNOS; [M+H]+; delta(ppm) 4.386261
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H29NO5; [M+H]+; delta(ppm) 0.087048
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.467; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; CCCCCCCCCC(=O)CC(=O)NC(CCO)C(=O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.446; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; N=1N=C(OC1C2=CN=CN2C)C3CN(CC3)CC4CCCCC4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.335; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N=1OC(=NC1C=2C=NC(=CC2)N(C)C)C3N(CCC3)CC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.322; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; CC[C@H](C)[C@](O)([C@H](C)O)C(=O)OC[C@H]1CC[N@+]2([O-])CCC[C@H]12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.313; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; CCCCC(CC)CNC(=O)CC(C)OC(=O)CCC(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.468; LLMHHTKQXBQMLZ-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.424; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; Butoctamide hydrogen succinate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.170; RADBWKDPINYLDT-MWJGYPJQNA-N; [M+H]+; UNPD52456
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.163; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; UNPD166734
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.160; IYYIBVLOYINRIB-UHFFFAOYSA-N; [M+H]+; (4-hydroxy-2,3,5,7a-tetrahydro-1H-4??-pyrrolizin-7-yl)methyl 2-hydroxy-2-(1-hydroxyethyl)-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.087; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; (2S)-4-hydroxy-2-(3-oxododecanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.577; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclohexylmethyl)pyrrolidin-3-yl]-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.471; KIVDABLXRBLKPT-UHFFFAOYSA-N; [M+H]+; 1-{4-[1-(2-cyanoethyl)-3,5-dimethyl-1H-pyrazol-4-yl]cyclopent-2-en-1-yl}-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.426; QVAZDUQDJPUMOS-UHFFFAOYSA-N; [M+H]+; 5-{5-[1-(2,2-dimethylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}-N-methylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.371; MCYRPUWJNNPZAT-UHFFFAOYSA-N; [M+H]+; N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.340; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-{5-[1-(2-methylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KIVDABLXRBLKPT-UHFFFAOYSA-N; [M+H]+; 1-{4-[1-(2-cyanoethyl)-3,5-dimethyl-1H-pyrazol-4-yl]cyclopent-2-en-1-yl}-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; Butoctamide hydrogen succinate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; MCYRPUWJNNPZAT-UHFFFAOYSA-N; [M+H]+; N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.843; RADBWKDPINYLDT-MWJGYPJQNA-N; [M+H]+; UNPD52456
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.726; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; UNPD166734
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.691; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclohexylmethyl)pyrrolidin-3-yl]-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.663; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-{5-[1-(2-methylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; QVAZDUQDJPUMOS-UHFFFAOYSA-N; [M+H]+; 5-{5-[1-(2,2-dimethylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}-N-methylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.280; LLMHHTKQXBQMLZ-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.024; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; (2S)-4-hydroxy-2-(3-oxododecanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.583; CQONVBIGUJWUFE-UHFFFAOYSA-N; [M+H]+; 4-[4-(2-ethylhexylamino)-4-oxobutan-2-yl]oxy-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.370; VCRXMSMANOGRCM-ZDUSSCGKSA-N; [M+H]+; (2S)-2-(dodecanoylamino)butanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; SQTHUAITVREGCH-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-[3-(4-methylpiperazin-1-yl)propyl]-3H-pyrido[2,3-b][1,4]diazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.816; MHJDREYXLOFFDT-UHFFFAOYSA-N; [M+H]+; 4-amino-N-[2-(diethylamino)ethyl]-6,7-dimethylcinnoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.570; BSQIJYAFXZDYBP-UHFFFAOYSA-N; [M+H]+; 7-methyl-2-(4-piperidin-1-ylpiperidin-1-yl)-5H-pyrrolo[2,3-d]pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; PCNAKWUTWPAVMZ-UHFFFAOYSA-N; [M+H]+; 2-[carboxymethyl(dodecanoyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.877; PCNAKWUTWPAVMZ; [M+H]+; Lauroyliminodiacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.495; IJMMECIIPUTJIH; [M+H]+; Boc-achpa
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.029; CQONVBIGUJWUFE; [M+H]+; Listomin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.064; WOIAAVJAGKBTTQ; [M+H]+; N-(3-oxododecanoyl)-L-homoserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.489; RADBWKDPINYLDT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.603; IOELOYWUEMCABZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.675; LLMHHTKQXBQMLZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.118; PCNAKWUTWPAVMZ; [M+H]+; Lauroyliminodiacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -244.004; WNNIPDUXFOFCJZ; [M+H]+; 3-Oxononanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -265.974; CQONVBIGUJWUFE; [M+H]+; Butoctamide semisuccinate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -280.367; GVVWHMARXUIYDC; [M+H]+; 6-Hydroxynon-3-enoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -289.617; PCNAKWUTWPAVMZ; [M+H]+; Glycine, N-(carboxymethyl)-N-(1-oxododecyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -302.795; KBTYBCOHAXBCAS; [M+H]+; 4-Oxononanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.182; AHMPHMICBWOASN; [M+H]+; 6-Oxononanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -304.110; IJMMECIIPUTJIH; [M+H]+; (4S)-5-cyclohexyl-3-hydroxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -307.057; IIKLNAQQHGNSRA; [M+H]+; 9-Oxononanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.026; SYXWNBIKWCHJBE; [M+H]+; 8-Oxononanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -310.521; ZBHYMNYETSSWIX; [M+H]+; 6-Hydroxynon-4-enoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.164; WNNIPDUXFOFCJZ; [M+H]+; 3-Oxononanoylcarnitine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C16H30N1O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 5.300
MS$FOCUSED_ION: PRECURSOR_M/Z 316.211877
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2903000000-f84ba2a1bb0a07e72f78
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  57.0700749 16.4908 57.070791 0.9462 4.17 0.5195 21 f{C4H9}/3.47ppm,p-C12H21N1O5
  58.0653743 36.8018 58.066095 1.0161 6.08 0.8872 26 f{C3H8N1}/4.28ppm,p-C13H22O5
  62.0602529 50.5366 62.060986 0.8218 4.93 0.9310 27 f{C2H8N1O1}/3.43ppm,p-C14H22O4
  67.0543678 20.1311 67.055109 1.1334 5.17 0.8230 27 f{C5H7}/2.11ppm,p-C11H23N1O5
  81.0699310 152.5972 81.070657 0.3824 12.57 0.9359 27 f{C6H9}/0.67ppm,p-C10H21N1O5
  84.0808282 129.4956 84.081544 0.4044 11.61 0.9646 27 f{C5H10N1}/0.62ppm,p-C11H20O5
  95.0855300 25.6412 95.086182 1.2620 5.54 0.7492 25 f{C7H11}/0.03ppm,p-C9H19N1O5
  102.0913607 999.0000 102.091954 0.2939 0.00 0.9505 27 f{C5H12N1O1}/0.20ppm,p-C11H18O4
  103.0946701 43.3319 103.095254 1.4162 5.49 0.9214 26 ?
  115.0389410 54.0834 115.039424 1.1301 5.38 0.9278 24 f{C5H7O3}/-0.26ppm,p-C11H23N1O2
  123.1168483 170.5518 123.117257 0.4386 13.48 0.9164 27 f{C9H15}/0.17ppm,p-C7H15N1O5
  128.1071230 40.1034 128.107479 1.1475 6.75 0.8722 24 f{C7H14N1O1}/1.03ppm,p-C9H16O4
  184.1697010 14.4496 184.170100 1.4009 4.00 0.6675 21 f{C11H22N1O1}/0.60ppm,p-C5H8O4
  316.2117844 463.1305 316.212204 0.6894 33.15 1.0000 27 f{C16H30N1O5}/-0.21ppm,p
  317.2153662 72.0691 317.215787 0.9205 6.37 0.9289 22 ?
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  57.070075 16.49 16
  58.065374 36.80 36
  62.060253 50.54 50
  67.054368 20.13 20
  81.069931 152.60 152
  84.080828 129.50 129
  95.085530 25.64 25
  102.091361 999.00 999
  103.094670 43.33 43
  115.038941 54.08 54
  123.116848 170.55 170
  128.107123 40.10 40
  184.169701 14.45 14
  316.211784 463.13 463
  317.215366 72.07 72
//
